Stay updated on SRX246 in Huntington's Disease: Tolerability Clinical Trial
Sign up to get notified when there's something new on the SRX246 in Huntington's Disease: Tolerability Clinical Trial page.

Latest updates to the SRX246 in Huntington's Disease: Tolerability Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe record displays details for the completed Phase 2 study of SRX246 for irritability in people with Huntington’s disease, including its study plan, eligibility criteria, participating locations, outcomes, and linked documents.SummaryDifference58%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page for the NCT02507284 trial now displays a 403 Forbidden error, replacing the usual study details with an access-denied page. This indicates that the trial information is temporarily unavailable due to access restrictions.SummaryDifference18%

Stay in the know with updates to SRX246 in Huntington's Disease: Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SRX246 in Huntington's Disease: Tolerability Clinical Trial page.